Globe Life (NYSE:GL – Get Free Report) issued its earnings results on Wednesday. The company reported $3.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.12 by $0.02, Zacks reports. Globe Life had a net margin of 19.04% and a return on equity of 22.91%. Globe Life updated its FY 2025 guidance to 13.450-14.050 EPS.
Globe Life Stock Performance
Shares of Globe Life stock traded up $0.52 during trading on Wednesday, reaching $122.93. The company’s stock had a trading volume of 587,098 shares, compared to its average volume of 551,996. The business’s fifty day moving average price is $112.56 and its 200-day moving average price is $106.41. Globe Life has a one year low of $38.95 and a one year high of $132.00. The firm has a market cap of $10.32 billion, a price-to-earnings ratio of 10.40 and a beta of 0.81. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.05 and a current ratio of 0.05.
Globe Life Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Monday, January 6th were given a $0.24 dividend. This represents a $0.96 annualized dividend and a dividend yield of 0.78%. The ex-dividend date was Monday, January 6th. Globe Life’s dividend payout ratio is currently 8.12%.
Insider Buying and Selling at Globe Life
Wall Street Analysts Forecast Growth
A number of research firms recently issued reports on GL. Piper Sandler lifted their price objective on Globe Life from $118.00 to $130.00 and gave the company an “overweight” rating in a research report on Friday, October 25th. Jefferies Financial Group lifted their price target on Globe Life from $107.00 to $114.00 and gave the company a “hold” rating in a report on Tuesday, December 10th. Keefe, Bruyette & Woods increased their price objective on Globe Life from $135.00 to $137.00 and gave the stock an “outperform” rating in a report on Friday, January 10th. Truist Financial lifted their target price on shares of Globe Life from $90.00 to $105.00 and gave the company a “hold” rating in a research note on Friday, October 25th. Finally, Raymond James increased their price target on shares of Globe Life from $160.00 to $188.00 and gave the stock a “strong-buy” rating in a research note on Tuesday, October 15th. Five equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $132.18.
Get Our Latest Report on Globe Life
Globe Life Company Profile
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Featured Stories
- Five stocks we like better than Globe Life
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- 3 Must-Have ETFs Set to Dominate This Quarter
- The 3 Best Fintech Stocks to Buy Now
- Seeking Stability? These 3 Stocks Offer Strong Potential
- Energy and Oil Stocks Explained
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.